USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
08 Jul 2021 | 02:30 PM GMT

D2C Launch for Medical Device in the US

Anchored by:

Jim Joyce
Director
CLEAR IP
Veronica Pierni
Lecturer, Entrepreneurial Studies
BENTLEY UNIVERSITY

Participants:

Jim Joyce DirectorClear IP
Jim Joyce
DirectorClear IP
Veronica Pierni Lecturer, Entrepreneurial StudiesBentley University
Veronica Pierni
Lecturer, Entrepreneurial StudiesBentley University
Aman Bhatti CEO, Member Board of DirectorsCumulus Neuroscience
Aman Bhatti
CEO, Member Board of DirectorsCumulus Neuroscience
Gareth Jones VP, Strategic Business Dev & InvestmentZepp Health
Gareth Jones
VP, Strategic Business Dev & InvestmentZepp Health
Jill Pierse Director of Business TransformationHealth Beacon
Jill Pierse
Director of Business TransformationHealth Beacon
Jill Pierse Director of Business TransformationHealthBeacon
Jill Pierse
Director of Business TransformationHealthBeacon
Laura Hamilton EVP of Business DevelopmentHealthBeacon
Laura Hamilton
EVP of Business DevelopmentHealthBeacon
Monica Bush Global Product Marketing DirectorGE HealthCare
Monica Bush
Global Product Marketing DirectorGE HealthCare
RG
Rob George VP Corporate DevelopmentHamilton Beach Health
RG
Rob George
VP Corporate DevelopmentHamilton Beach Health
Rob Milnes CEOviO HealthTech
Rob Milnes
CEOviO HealthTech
Robert Garber Managing Partner7wireVentures
Robert Garber
Managing Partner7wireVentures

About this Meeting

D2C can be an attractive route to market for some Medical Devices companies since it can lead to easier gain of traction and fast revenues. However, there are also challenges to consider before launching. Join us in this interactive session where we will explore what we need to take into account for the D2C launch of Medical Devices in the US. Areas of focus include:  
  •  Marketing channels - what has worked so far (e.g pros and cons of using Social Media, influencers, etc).  
  •  Pre-tax accounts that individuals can use to pay for healthcare-related expenses (FSAs, HSAs) - How best to leverage the infrastructure (marketing/advertising strategic direction). Subset of marketing channels. 
  • Regulatory challenges and barriers to go D2C (e.g FDA post marketing surveillance, etc) 
  •  Lessons learned from companies that have gone D2C, like Fitbit, AliveCor or LetsGetChecked